Podcast Episodes
Back to Search
Episode 178: ASCO 2022: Germline variants in men of African descent with prostate cancer
Season 1 Episode 178
Veda Giri gives an overview of her presentation at ASCO 2022.
4 years, 4 months ago
Episode 177: ASCO 2022: ENZAMET survival update
Season 1 Episode 177
Ian Davis describes the implications of the study.
4 years, 4 months ago
Episode 176: ASCO 2022: HER-2 ADCs in Bladder Cancer
Season 1 Episode 176
Matt Galski discusses data from ASCO 2022.
4 years, 4 months ago
Episode 175: ASCO 2022: Targeting the microbiome in renal cancer
Season 1 Episode 175
Nazli Dizman describes her latest data on CBM588 in renal cancer.
4 years, 4 months ago
Episode 174: ASCO 2022: Cell free DNA as a biomarker in bladder cancer
Season 1 Episode 174
Amir Goldkorn describes translational findings from a phase 2 bladder trial.
4 years, 4 months ago
Episode 173: ASCO 2022: The Atlantis Trial - maintenance cabozantinib in bladder cancer
Season 1 Episode 173
Rob Jones describes cabozantinib in urothelial cancer.
4 years, 4 months ago
Episode 172: ASCO 2022: Adjuvant everolimus in renal cancer
Season 1 Episode 172
Chris Ryan describes the results of this adjuvant study.
4 years, 4 months ago
Episode 171: Antibody drug conjugates in bladder cancer: managing adverse effects
Season 1 Episode 171
Jonathan Rosenberg gives an overview of the current landscape.
4 years, 5 months ago
Episode 170: APCCC Meeting Summary
Season 1 Episode 170
Silke Gillessen and Chris Sweeney summarise the meeting.
4 years, 5 months ago
Episode 169: The Uromigos Paper of the Month - Novel neoadjuvant approaches in UC
Season 1 Episode 169
Syed Hussein and Sam Funt describe their studies.
4 years, 5 months ago